Orphan designation: sargramostim Treatment of pulmonary alveolar proteinosis, 28/06/2024 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 22 August 2024 - 15:38

Orphan designation: sargramostim Treatment of pulmonary alveolar proteinosis, 28/06/2024 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-24-2928

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters